Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE. (2021)
Attributed to:
Institute of Cancer Research Confidence in Concept (ICR CiC)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2021.01.018
PubMed Identifier: 33601323
Publication URI: http://europepmc.org/abstract/MED/33601323
Type: Journal Article/Review
Volume: 146
Parent Publication: European journal of cancer (Oxford, England : 1990)
ISSN: 0959-8049